BLZ945

· Novartis Pharmaceuticals

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for BLZ945, covering 2024-01-18 to 2025-03-19. Get the full timeline:

Most recent: Clinical Trial Update: Study of Safety and Proof of the Mechanism of BLZ945 in ALS Patients [Phase 2]